What portion of EBITDA improvement is from inventory gains and how much is reversible?

Inventory gains were a small component; margin improvement is structural due to higher-value orders, operating leverage, and cost optimization. EBITDA should be in 10-12% range going forward, with upside from new products.

Why has FY28 Dahej utilization guidance been reduced from 65-70% to 50-60%, and margin guidance raised from 13-14% to 14-15%?

Earlier we planned Dahej start in H1, now it's Q3, so we are conservative; still targeting close to 60% but setting conservative range 50-60%. Margins raised due to new product launches and cost initiatives.

Capex details for Naidupeta debottlenecking and FY27 9-month spend?

Exact capex figure I'll need to check and come back offline.

How quickly can Dahej ramp up and what will be customer mix?

Ramp up to 50-60% in FY28, 70-80% by FY29; customer mix ~60% tyre, 40% others (ceramics, agri, specialty).

What is the market size and margin profile of new products like LabPure and ZRA?

These are niche, higher-margin products solving specific customer problems; will be sticky once adopted, ramp-up gradual.

J.G.Chemicals Q1 FY27 Earnings Call — Analysis (NSE: JGCHEM)

JG Chemicals delivers record Q1FY27 with revenue ₹315.7 Cr (+44.8% YoY), EBITDA margin 11.5%; Dahej greenfield and Naidupeta brownfield on track for Q3 FY27 commissioning, margin target raised to 14-15%.

13 Aug 2026 · Analysis by Alpha Inflection

Result quality: strong — Margin expansion. Management sentiment: optimistic.

The take

Q1FY27 Revenue ₹315.7 Cr ( +44.8% YoY ) . New guidance — dahej phase 1 capacity and econ… 15,000-17,000 tons; ₹300-400 Cr; 11-12% . New story: Capacity expansion to top-3 global scale .

Results

Revenue ₹315.7 Cr +44.8% YoY (+10.3% QoQ), EBITDA ₹36.3 Cr margin 11.5% (+86bps YoY), PAT ₹26.1 Cr margin 8.27% (+75bps YoY).

Financial highlights

J.G.Chemicals Q1 FY27 reported figures
Metric	Value	Change	Basis
Revenue	₹315.7 Cr	+44.8%	yoy · Q1FY27 · YoY growth 44.8%; QoQ growth 10.3%
EBITDA	₹36.3 Cr	+86bps	yoy · Q1FY27 · EBITDA margin 11.5% vs 10.64% in Q1 FY26
PAT	₹26.1 Cr	+75bps	yoy · Q1FY27 · PAT margin 8.27% vs 7.52% in Q1 FY26
EBITDA Margin	11.5%	+86bps	yoy · Q1FY27 · Compared to 10.64% in Q1 FY26
PAT Margin	8.27%	+75bps	yoy · Q1FY27 · Compared to 7.52% in Q1 FY26

Guidance

Dahej Phase 1 commissioning November 2026 (Q3 FY27), FY28 utilisation 50-60%, consolidated EBITDA margin target raised to 14-15% by FY29 driven by value-added products and non-tire mix.

What management committed to

Dahej greenfield Phase 1 zinc oxide production will be commissioned in Q3 FY27, around November 2026. — Q3 FY27, Q3FY27
Dahej Phase 1 capacity will be 15,000-17,000 tons per annum, with revenue potential of INR 300-400 crores and EBITDA margin of 11-12%. — 15,000-17,000 tons; INR 300-400 Cr; 11-12%
FY28 utilisation for Dahej plant will be a minimum of 50-60%. — 50-60%, FY28
FY29 utilisation for Dahej plant will reach 70-80%, and Phase 2 expansion construction will have started by then. — 70-80%, FY29
Consolidated EBITDA margin target raised to 14-15%, driven by higher share of value-added products and non-rubber applications, likely by FY29. — 14-15%, FY29
Current quarter (Q2 FY27) is experiencing similar margin profile and momentum as Q1 FY27. — similar, Q2FY27
Recycled rubber project [JG TUR] commercial operations expected to begin within the next 12 months. — within the next 12 months
Naidupeta brownfield expansion of 5,000 tons will be commissioned in Q3 FY27. — 5,000 tons, Q3FY27
Payback period for Dahej and other capex projects will be 3-4 years, with ROCE in mid-20s. — 3-4 years, mid-20s ROCE, going forward

Key themes

Capacity expansion and margin-accretive product mix shift

How the narrative shifted

Capacity expansion to top-3 global scale: Management is adding significant zinc oxide capacity via Dahej greenfield and Naidupeta brownfield to capture demand and drive scale, positioning as top-3 global producer.
Product mix shift to non-tire specialty: Shift towards ceramics, pharma, specialty chemicals expected to lift margins; non-rubber share reached 18%, with Dahej enabling further shift in western India.
Tire industry capex tailwind: Indian tire manufacturers investing ~Rs 25,000 Cr capex; high capacity utilisation at tire customers supports sustained zinc oxide demand.
Raw material supply chain resilience: Geopolitical disruption has tightened zinc dross supply, but JGC's scale and relationships ensure uninterrupted raw material, reinforcing competitive moat.
Recycled rubber and ESG differentiation: JG TUR recycled rubber product addresses tire industry ESG needs; pilot success positions it as another growth adjacent, enhancing circularity narrative.
R&D-driven niche products: New high-margin specialty grades (LabPure, ZRA, patent-pending chemical) developed via strengthened R&D to create sticky customer solutions and pricing power.

Operational commentary

Dahej greenfield zinc chemical facility (40,000+ MTA total, Phase 1: 15,000-17,000 tons) civil work advanced, equipment installation underway, commissioning targeted November 2026 (Q3 FY27), revenue potential INR 300-400 Cr, expected EBITDA margin 11-12%.
Naidupeta brownfield expansion (5,000 tons) on track for Q3 FY27 commissioning, enhancing capacity to meet rising demand.
New product launches: LabPure high-purity zinc oxide for analytical reagents, JG-ZRA rubber activator for non-tire applications; advanced stage of patent for jointly developed chemical with improved processability.
Recycled rubber project branded JG TUR, pilot trials positive, commercial plan being developed; management expects commercial startup within 12 months, citing customer pull for ESG and recycled content.
Proposed incorporation of Dubai subsidiary BDJ Materials and Metal Trading FZCO to bolster raw material sourcing and global distribution.
Non-rubber share reached ~18% in Q1 (up YoY); ceramic market seeding underway, approval cycle 1-3 months vs 5 years for tires, positioning for rapid ramp-up post Dahej.
R&D centre inaugurated at Naidupeta plant, supporting new product development and polymer testing.
Exports at 10-15% of sales; targeting 15% with gradual increase.
Utilisation in early 80s (achievable capacity), volume growth double-digit across categories; management sees room to ramp up to full achievable capacity before new plants come online.

Analyst Q&A

Q. What portion of EBITDA improvement is from inventory gains and how much is reversible?
Inventory gains were a small component; margin improvement is structural due to higher-value orders, operating leverage, and cost optimization. EBITDA should be in 10-12% range going forward, with upside from new products.
Q. Why has FY28 Dahej utilization guidance been reduced from 65-70% to 50-60%, and margin guidance raised from 13-14% to 14-15%?
Earlier we planned Dahej start in H1, now it's Q3, so we are conservative; still targeting close to 60% but setting conservative range 50-60%. Margins raised due to new product launches and cost initiatives.
Q. Capex details for Naidupeta debottlenecking and FY27 9-month spend?
Exact capex figure I'll need to check and come back offline.
Q. How quickly can Dahej ramp up and what will be customer mix?
Ramp up to 50-60% in FY28, 70-80% by FY29; customer mix ~60% tyre, 40% others (ceramics, agri, specialty).
Q. What is the market size and margin profile of new products like LabPure and ZRA?
These are niche, higher-margin products solving specific customer problems; will be sticky once adopted, ramp-up gradual.

View source

Research and educational content only. Not investment advice.